XNAS · OMCL
-2.74% · -$1.28 · Vol 648.8K
Market closed · last close 4:00 PM ET · price as of 18:23:15 ET
Omnicell Inc

Omnicell Inc

ELECTRONIC COMPUTERS
$45.40
+ Add to watchlist
Card
Relationship Map

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

Score not reportedVeridion does not publish a score-history trend for OMCL until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
NO SCORE SNAPSHOT COVERAGE
AI Analysis
Sovereign

Why is OMCL moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for OMCL are being assembled.
About Omnicell Inc
ELECTRONIC COMPUTERS
Listed since
2001
Employees
4K
Country
US

Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$46.43
Day high
$46.78
Day low
$44.75
Previous close
$46.68
52W high
$46.78
-2.96% from high
52W low
$44.75
32% of range
Market cap
$2.1B
P/E
133.53×
EPS
$0.3400
Shares out
45.5M
Volume
648.8K
VWAP
$45.79
Price history computed in-house
SMA 50 Not reported · Not reported
SMA 200 Not reported · Not reported
52W position 32%
Veridion warehouse edge

Warehouse intelligence for OMCL.

Veridion Score
Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Related public evidence

Continue the OMCL research trail.

Relationship mapTrace receipt-backed holders and filings around OMCL.Congress disclosuresOpen receipt and filing context for OMCL.MethodologyReview score inputs, coverage rules, and limitations.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

OMCL insider activity

Omnicell Inc

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for OMCL.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

OMCL contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for OMCL in this window.
Lobbying spend

OMCL lobbying filings, year to date.

Registered lobbying filings matched to Omnicell Inc.

$50.0K
Refresh interval: 12hSource: LDA disclosure filings
Medicare/Medicaid Health Issues
Filing
$50.0K
OMNICELL

POLSINELLI PC

Jan 14, 2026
Latest news · OMCL
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for OMCL.
Options
Sovereign unlock shows live options positioning for OMCL.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.